Cargando…

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk

A fatty liver index (FLI) greater than sixty (FLI ≥ 60) is an established score for metabolic dysfunction-associated steatotic liver disease (MASLD), which carries a high risk for diabetes and cardiovascular disease, while a FLI ≤ 20 rules out the presence of steatosis. Thus, we investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carli, Fabrizia, Sabatini, Silvia, Gaggini, Melania, Sironi, Anna Maria, Bedogni, Giorgio, Gastaldelli, Amalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572624/ https://www.ncbi.nlm.nih.gov/pubmed/37834099 http://dx.doi.org/10.3390/ijms241914651

Ejemplares similares

Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease
por: Gaggini, Melania, et al.
Publicado: (2019)

The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
por: Saponaro, Chiara, et al.
Publicado: (2015)

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
por: Gaggini, Melania, et al.
Publicado: (2013)

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
por: Bedogni, Giorgio, et al.
Publicado: (2006)

Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases
por: Carli, Fabrizia, et al.
Publicado: (2022)

Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2022)

PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
por: Gastaldelli, Amalia, et al.
Publicado: (2021)

A simple index of lipid overaccumulation is a good marker of liver steatosis
por: Bedogni, Giorgio, et al.
Publicado: (2010)

Diet and Exercise in the Treatment of Fatty Liver
por: Magkos, Faidon, et al.
Publicado: (2012)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2021)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023)

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
por: Maev, Igor V, et al.
Publicado: (2020)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2022)

Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
por: Gaggini, Melania, et al.
Publicado: (2023)

Automated assessment of steatosis in murine fatty liver
por: Sethunath, Deepak, et al.
Publicado: (2018)

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study
por: Foschi, Francesco Giuseppe, et al.
Publicado: (2018)

Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease
por: Gaggini, Melania, et al.
Publicado: (2022)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes
por: Bozkurt, Latife, et al.
Publicado: (2012)

Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes
por: Wang, Chenxi, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome
por: Chen, Li-Da, et al.
Publicado: (2019)

Not only loud but also intelligible
por: Foltynie, Tom, et al.
Publicado: (2020)

Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity
por: Leone, Alessandro, et al.
Publicado: (2022)

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes
por: Meroni, Marica, et al.
Publicado: (2020)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

Development and Internal Validation of Fatty Liver Prediction Models in Obese Children and Adolescents
por: Bedogni, Giorgio, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
por: Pirozzi, Anna Virginia Adriana, et al.
Publicado: (2020)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Not Only Scientists, but Also Responsible Citizens
por: Watt, Graham C M
Publicado: (1998)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fhp718ul6ldfbrujfmhvodbto0